Pharmaceuticals: DSM Joint Venture Percivia Ceases Inhouse Activities
08:53 AM | April 26, 2012 | Alex Scott
DSM and Crucell (Leiden, the Netherlands), a biotech firm, have pulled the plug on all inhouse projects at their biosimilar drugs joint venture company Percivia (Cambridge, MA). Set up in 2007, ...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.